We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Infrared Spectroscopy Combined with AI Automates Detection of Staphylococcus aureus

By LabMedica International staff writers
Posted on 24 Jul 2013
The combination of Fourier transform infrared spectroscopy (FTIR) and artificial neuronal network (ANN) analysis constitutes a system that allows rapid identification and discrimination of the clinically important Staphylococcus aureus capsular serotypes 5, 8, and NT (nontypeable).

The term Fourier transform infrared spectroscopy originates from the fact that a Fourier transform is required to convert the raw data into the actual spectrum. More...
An instrument employing this technique shines a beam containing many frequencies of light at once, and measures how much of that beam is absorbed by the sample. Next, the beam is modified to contain a different combination of frequencies, giving a second data point. This process is repeated many times. Afterwards, a computer takes all these data and works backwards to infer what the absorption was at each wavelength.

Investigators at the University of Veterinary Medicine (Vienna, Austria) combined FTIR spectroscopy with a computerized self-learning system known as an artificial neuronal network (ANN). A comprehensive set of clinical isolates derived from different origins and control strains, representative for each serotype was used to "teach" the system to recognize the spectra emitted by the capsular polysaccharides (CP) present on the surface of the clinically relevant strains of S. aureus.

Studies carried out with the high-throughput ANN-assisted FTIR spectroscopy CP typing system yielded overall accuracy of 96.7% for internal validation and 98.2% for external validation. These results support the use of this system for diagnostic as well as large-scale epidemiologic surveillance of S. aureus capsule expression,

Senior author Dr. Monika Ehling-Schulz, professor of functional microbiology at the University of Veterinary Medicine, said, "In principle, germs have two choices when they infect a host: attack or hide—in technical terms virulence or persistence. If they attack, they risk destroying the host and consequently themselves, whereas if they hide, they may be outcompeted by others. A detailed knowledge of the mechanisms of virulence and persistence and the way bacteria switch between them will help us to develop novel and more effective therapies."

A full description of the ANN-assisted FTIR spectroscopy CP typing system was published in the July 2013 issue of the Journal of Clinical Microbiology.

Related Links:
University of Veterinary Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image: The proposed workflow adds liquid biopsy to detect genetic and molecular signs of cancer in CSF samples already collected during autoimmune encephalitis evaluation. (Image Credit: Shutterstock)

CSF Liquid Biopsy Could Help Distinguish Cancer from Autoimmune Brain Inflammation

Autoimmune encephalitis can cause memory and behavioral changes, seizures, and altered consciousness, but diagnosis can be challenging because cancers involving the brain and central nervous system may... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.